Never Run Out Of Buyers To Sell To.

At DCN Corp® we hope to transform Nano-tech into accessible and life-enhancing diagnostic platform technologies. Our proprietary platform technology is validated to TRL 3, and protected by a robust hybrid IP strategy- What We Do: We’ve developed a useful Surface Plasmon Resonance (SPR) process technology, designed for next-gen diagnostics. It enables- Real-time biological insights - Quantitative severity analysis - Compatibility with Raman & Infrared instruments This innovation should evolve into a scalable handheld bio-kit for early detection and precision diagnostics- Our Mission: To…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$1M to $5M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.